Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
By Carmine Zoccali, F. Mallamaci, Giovanni Tripepi, F. Benedetto, S. Cutrupi, S. Parlongo, L. Malatino, G. Bonanno, G. Seminara, F. Rapisarda and 8 more. Journal of the American Society of Nephrology, 2002
813 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/72b2a776fa9796764d51efa65c36334e167ac84c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex (2003, background): “In this study we found that both IAF and adiponectin were major correlates of plasma lipoproteins, in particular of LDL buoyancy (Rf) and HDL cholesterol concentrations, in keeping with other reports [31, 34, 64].”
- Plasma adiponectin levels and risk of myocardial infarction in men. (2004, result): “Consistent with these animal studies, low adiponectin levels were found in participants with coronary artery disease.(5,43,45)”
- Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. (2002, background): “Second, the degree of hypoadiponectinemia correlated with the incidence of fatal heart ischemia in the subjects with chronic renal failure (24).”
- Adiponectin: more than just another fat cell hormone? (2003, background): “The incidence of cardiovascular death has been found to be higher in patients with renal failure who have decreased adiponectin levels (hypoadiponectinemia) (34).”
- Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008, background): “the role of adipokines, such as adiponectin (57), leptin (58), and”
- Adiponectin: action, regulation and association to insulin sensitivity (2005, background): “To date, little is known about adiponectin clearance, however, both renal and hepatic clearance have been suggested (59,60).”